Thursday, March 23, 2006

FDA panel rejects placing toughest warnings on ADHD drugs

From the CEC Smart Brief:

A Food and Drug Administration pediatric advisory committee recommended Wednesday that Ritalin and other drugs used to treat ADHD contain a warning about potential cardiovascular and psychiatric risks, but not the strongest possible "black-box" caution that an FDA drug safety advisory committee in February had called for. The FDA has not found a definitive link between the drugs and reported psychiatric events in users. Press (3/23)

No comments:

Promethean Planet


The following is the opinion of the writer and is not intended to malign any religion, ethnic group, club, organization, company, or individual. Any view or opinion represented in the blog comments are personal and is accredited to the respective commentor / visitor to this blog. This blogger reserves the right to moderate comment suitability in support of respecting racial, religious and political sensitivities, and in order to protect the rights of each commentor where available.